Seres Therapeutics Inc Stock Performance
as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
$16.88$17.99
3.93%
Downside
2.39%
Upside
52 Week's Low
52 Week's High
$6.53$24.6762.83%
Downside
40.38%
Upside
Seres Therapeutics Inc share price movements today
- Previous Close
- $17.40
- Open
- $17.52
- Volume
- 237.5K
- Day's Low - High
- $16.88 - $17.99
- 52 Week Low - High
- $6.53 - $24.67
Seres Therapeutics Inc Historical Returns
- 1 Month Return
- -5.99 %
- 3 Month Return
- + 114.34 %
- 1 Year Return
- -28.68 %
- 3 Year Return
- -88.74 %
- 5 Year Return
- -97.08 %
Seres Therapeutics Inc Stock Fundamentals & Key Indicators
Check Seres Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$137.4M
EPS (TTM)
1.75
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.74
Industry PE ratio
-3.9281873111782475
P/B Ratio
0PEG Ratio
-0.11
EBITDA
-105.5M
Revenue (TTM)
126.3M
Profit Margin
0.00%
Return On Equity TTM
49836900.00%
Seres Therapeutics Inc Stock Valuation
Track how Seres Therapeutics Inc P/E has moved over time to understand its valuation trends.
Seres Therapeutics Inc in the last 5 years
Lowest (0.00x)
September 17, 2025
Industry (-3.93x)
September 17, 2025
Today (-0.74x)
September 17, 2025
Highest (0.00x)
September 17, 2025
Today’s Price to Earnings Ratio: -0.74x
Seres Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Seres Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $137.4M | -97.08% | -0.74 | 0.00% | |
| BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
| NA | $39.0B | NA | NA | -3.89% | |
| BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
| BUY | $59.6B | 1.78% | 14.1 | 31.37% |
Stock Returns calculator for Seres Therapeutics Inc Stock including INR - Dollar returns
The Seres Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Seres Therapeutics Inc investment value today
Current value as on today
₹84,462
Returns
Returns from Seres Therapeutics Inc Stock
Dollar Returns*
₹4,598 (+4.6%)
Analyst Recommendation on Seres Therapeutics Inc Stock
Based on 13 analysts
76.92%
Buy
15.38%
Hold
7.69%
Sell
Based on 13 analysts, 76.92% of analysts recommend a 'BUY' rating for Seres Therapeutics Inc. Average target price of $13.33
Seres Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Seres Therapeutics Inc.
What analysts predicted
-31.81%DOWNSIDE
Target Price
$13.33
Current Price
$17.57
Analyzed by
13 Analysts
Target
$13.33
Seres Therapeutics Inc target price $13.33, a slight downside of -31.81% compared to current price of $17.57. According to 13 analysts rating.
Seres Therapeutics Inc Stock's Interest Amongst Investors
Search interest for Seres Therapeutics Inc Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Seres Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Seres Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Seres Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Seres Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Global Institutional Holdings in Seres Therapeutics Inc
Insights on Seres Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 64.0K → 5.95M (in $), with an average increase of 98.9% per quarter
- POSITIVE IMPACT
Price Rise
In the last 3 months, MCRB stock has moved up by 125.1%
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 204.0%
- NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 86.0%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 32.68M → -19.85M (in $), with an average decrease of 160.8% per quarter
About Seres Therapeutics Inc
| Organisation | Seres Therapeutics Inc |
| Headquarters | 101 Cambridgepark Drive, Cambridge, MA, United States, 02140 |
| Industry | Health Technology |
| CEO | Mr. Thomas J. DesRosier Esq., J.D. |
| E-voting on shares | Click here to vote |
Key Management of Seres Therapeutics Inc
Name | Title |
|---|---|
Ms. Caroline Hensley | Assistant General Counsel |
Mr. Thomas J. DesRosier Esq., J.D. | Co-CEO, Co-President & Chief Legal Officer |
Ms. Marella Thorell CPA | Co-CEO, Co-President & CFO |
Dr. Matthew R. Henn Ph.D. | Executive VP & Chief Scientific Officer |
Dr. Teresa L. Young Ph.D., R.Ph. | Executive VP and Chief Commercial & Strategy Officer |
Mr. Chris McChalicher | Senior VP of Manufacturing, Quality, and Process Development |
Dr. Dennis M. Walling M.D. | Senior VP of Clinical Development & Head of Clinical Research |
Ms. Ann Kurowski | Senior Vice President of Regulatory Affairs |
Ms. Kelly Brady | Senior Vice President of Clinical Development |
FAQs
What is Seres Therapeutics Inc share price today?
Seres Therapeutics Inc share price today is $17.57 as on at the close of the market. Seres Therapeutics Inc share today touched a day high of $17.99 and a low of $16.88.
What is the 52 week high and 52 week low for Seres Therapeutics Inc share?
Seres Therapeutics Inc share touched a 52 week high of $24.67 on and a 52 week low of $6.53 on . Seres Therapeutics Inc stock price today i.e. is closed at $17.57,which is 28.77% down from its 52 week high and 169.07% up from its 52 week low.
What is Seres Therapeutics Inc's market capitalisation today?
Seres Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Seres Therapeutics Inc Stock (MCRB) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Seres Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Seres Therapeutics Inc Shares that will get you 0.0854 shares as per Seres Therapeutics Inc share price of $17.57 per share as on September 18, 2025 at 1:29 am IST.
What is the minimum amount required to buy Seres Therapeutics Inc Stock (MCRB) from India?
Indian investors can start investing in Seres Therapeutics Inc (MCRB) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Seres Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Seres Therapeutics Inc share’s latest price of $17.57 as on September 18, 2025 at 1:29 am IST, you will get 0.5692 shares of Seres Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Seres Therapeutics Inc has given to Indian investors in the last 5 years?
Seres Therapeutics Inc stock has given -97.08% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?